• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在两个有早发性阿尔茨海默病的韩国家庭中发现的 p.Thr116Ile 变异。

p.Thr116Ile Variant in Two Korean Families with Young Onset Alzheimer's Disease.

机构信息

Department of Bionano Technology, Gachon University, Sungnam 13120, Korea.

Department of Neurology, Korea University Guro Hosipital, Korea University, Seoul 08308, Korea.

出版信息

Int J Mol Sci. 2018 Sep 2;19(9):2604. doi: 10.3390/ijms19092604.

DOI:10.3390/ijms19092604
PMID:30200536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6164060/
Abstract

An in depth study of mutation p.Thr116Ile (c.335C>T) is presented from two Korean families with autosomal dominant inheritance. Clinical manifestation of our patients included memory loss, attention deficits, visuospatial dysfunction, agnosia, aphasia, apraxia, and personality changes, which occurred in their 30s. Thr116Ile was initially discovered in an Italian patient and two French families with early onset Alzheimer's disease (EOAD) with similar age of onset. To verify the possible pathogenic mechanisms of mutation, predictions and 3D modeling were performed. Structure predictions revealed significant aberrations in first hydrophilic loop (HL-I loop). The hydrophobic isoleucine could alter the loop orientation through increased hydrophobic contacts with the surrounding amino acids. Mutation could destroy a possible hydrogen bond between tyrosine 115 and threonine 116, which may affect the loop conformation. HL-I was confirmed as a conservative region of , which may be critical in functions. An additional pathogenic mutation, Thr116Asn, was also found for the same residue, where the patient presented young onset AD (YOND). Other mutations in HL-I loop, such as Tyr115His and Glu120Asp, were described in patients with YOND, supporting the critical role of HL-I loop in activity.

摘要

本研究深入探讨了两个常染色体显性遗传的韩国家族中突变 p.Thr116Ile(c.335C>T)。我们的患者临床表现包括记忆力减退、注意力缺陷、视空间功能障碍、失认症、失语症、失用症和人格改变,这些症状出现在他们 30 多岁时。Thr116Ile 最初在一名意大利患者和两个具有相似发病年龄的早发性阿尔茨海默病(EOAD)的法国家庭中发现。为了验证突变的可能致病机制,进行了预测和 3D 建模。结构预测显示,第一个亲水环(HL-I 环)存在明显的异常。疏水性异亮氨酸可能通过与周围氨基酸增加疏水接触来改变环的取向。突变可能破坏酪氨酸 115 和苏氨酸 116 之间可能的氢键,这可能影响环构象。HL-I 被证实为 保守区域,这可能对 功能至关重要。同一残基还发现了另一个致病突变 Thr116Asn,患者表现为早发性 AD(YOND)。HL-I 环中的其他突变,如 Tyr115His 和 Glu120Asp,在 YOND 患者中也有描述,支持 HL-I 环在 活性中的关键作用。

相似文献

1
p.Thr116Ile Variant in Two Korean Families with Young Onset Alzheimer's Disease.在两个有早发性阿尔茨海默病的韩国家庭中发现的 p.Thr116Ile 变异。
Int J Mol Sci. 2018 Sep 2;19(9):2604. doi: 10.3390/ijms19092604.
2
, and Mutations in Asian Patients with Early-Onset Alzheimer Disease.携带 PSEN1、PSEN2 和 APP 突变的早发性阿尔茨海默病亚洲患者。
Int J Mol Sci. 2019 Sep 25;20(19):4757. doi: 10.3390/ijms20194757.
3
Novel PSEN1 G209A mutation in early-onset Alzheimer dementia supported by structural prediction.结构预测支持早发性阿尔茨海默病痴呆中新型PSEN1 G209A突变
BMC Neurol. 2016 May 20;16:71. doi: 10.1186/s12883-016-0591-6.
4
A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.对韩国早发性阿尔茨海默病患者突变的基因筛查。
Clin Interv Aging. 2016 Dec 15;11:1817-1822. doi: 10.2147/CIA.S116724. eCollection 2016.
5
PSEN1 L226F mutation in a patient with early-onset Alzheimer's disease in Korea.韩国一名早发性阿尔茨海默病患者的PSEN1 L226F突变
Clin Interv Aging. 2016 Oct 12;11:1433-1440. doi: 10.2147/CIA.S111821. eCollection 2016.
6
Novel presenilin 1 mutation (p.I83T) in Tunisian family with early-onset Alzheimer's disease.突尼斯早发性阿尔茨海默病家族中的新型早老素1突变(p.I83T)
Neurobiol Aging. 2015 Oct;36(10):2904.e9-11. doi: 10.1016/j.neurobiolaging.2015.06.007. Epub 2015 Jun 12.
7
Identification of a Pathogenic PSEN1 Ala285Val Mutation Associated with Early-Onset Alzheimer's Disease.鉴定与早发性阿尔茨海默病相关的致病性 PSEN1 Ala285Val 突变。
Curr Alzheimer Res. 2020;17(5):438-445. doi: 10.2174/1567205017666200626210727.
8
Loss of stability and hydrophobicity of presenilin 1 mutations causing Alzheimer's disease.导致阿尔茨海默病的早老素1突变的稳定性和疏水性丧失。
J Neurochem. 2016 Apr;137(1):101-11. doi: 10.1111/jnc.13535. Epub 2016 Feb 11.
9
Identification of the Third Case of PSEN1 Tyr389His Variant in Early-Onset Alzheimer's Disease in Korea.韩国第三例早发性阿尔茨海默病 PSEN1 Tyr389His 变异的鉴定。
Int J Mol Sci. 2022 Dec 19;23(24):16192. doi: 10.3390/ijms232416192.
10
Novel PSEN1 p.Gly417Ala mutation in a Korean patient with early-onset Alzheimer's disease with parkinsonism.韩国一名早发性阿尔茨海默病伴帕金森病患者中新型 PSEN1 p.Gly417Ala 突变。
Neurobiol Aging. 2018 Dec;72:188.e13-188.e17. doi: 10.1016/j.neurobiolaging.2018.08.003. Epub 2018 Aug 9.

引用本文的文献

1
Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene.早老素-1(PSEN1)基因的遗传学、功能及临床影响
Int J Mol Sci. 2022 Sep 19;23(18):10970. doi: 10.3390/ijms231810970.
2
Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease.阿尔茨海默病中β-淀粉样肽与tau蛋白的相互作用
Neural Regen Res. 2022 Aug;17(8):1666-1674. doi: 10.4103/1673-5374.332127.
3
Pathogenic Thr119Ile Mutation in Two Korean Patients with Early-Onset Alzheimer's Disease.两名早发性阿尔茨海默病韩国患者中的致病性苏氨酸119异亮氨酸突变

本文引用的文献

1
Presynaptic endocytic factors in autophagy and neurodegeneration.自噬和神经退行性变中的突触前内吞因子。
Curr Opin Neurobiol. 2018 Feb;48:153-159. doi: 10.1016/j.conb.2017.12.018. Epub 2018 Jan 6.
2
A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.对韩国早发性阿尔茨海默病患者突变的基因筛查。
Clin Interv Aging. 2016 Dec 15;11:1817-1822. doi: 10.2147/CIA.S116724. eCollection 2016.
3
Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
Diagnostics (Basel). 2020 Jun 14;10(6):405. doi: 10.3390/diagnostics10060405.
4
Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment.用于轻度认知障碍诊断的潜在体液生物标志物。
Int J Mol Sci. 2019 Aug 25;20(17):4149. doi: 10.3390/ijms20174149.
5
A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer's disease.与早发性阿尔茨海默病相关的致病性 PSEN1 Trp165Cys 突变。
BMC Neurol. 2019 Aug 7;19(1):188. doi: 10.1186/s12883-019-1419-y.
6
Meta-Analysis of Gene Expression and Identification of Biological Regulatory Mechanisms in Alzheimer's Disease.阿尔茨海默病基因表达的荟萃分析及生物学调控机制的鉴定
Front Neurosci. 2019 Jul 3;13:633. doi: 10.3389/fnins.2019.00633. eCollection 2019.
7
Genetic analyses of early-onset Alzheimer's disease using next generation sequencing.利用下一代测序技术进行早发性阿尔茨海默病的遗传分析。
Sci Rep. 2019 Jun 10;9(1):8368. doi: 10.1038/s41598-019-44848-2.
8
Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer's Disease.分析 50 个神经退行性疾病基因在临床诊断早发性阿尔茨海默病中的作用。
Int J Mol Sci. 2019 Mar 26;20(6):1514. doi: 10.3390/ijms20061514.
常染色体显性遗传性阿尔茨海默病的临床表型和遗传相关性:病例系列研究。
Lancet Neurol. 2016 Dec;15(13):1326-1335. doi: 10.1016/S1474-4422(16)30193-4. Epub 2016 Oct 21.
4
Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease.早老素-1基因敲入小鼠揭示了家族性阿尔茨海默病的功能丧失机制。
Neuron. 2015 Mar 4;85(5):967-81. doi: 10.1016/j.neuron.2015.02.010.
5
Cooperative roles of hydrophilic loop 1 and the C-terminus of presenilin 1 in the substrate-gating mechanism of γ-secretase.早老素1亲水环1与C末端在γ-分泌酶底物门控机制中的协同作用。
J Neurosci. 2015 Feb 11;35(6):2646-56. doi: 10.1523/JNEUROSCI.3164-14.2015.
6
Clinical genetics of Alzheimer's disease.阿尔茨海默病的临床遗传学
Biomed Res Int. 2014;2014:291862. doi: 10.1155/2014/291862. Epub 2014 May 13.
7
The genetics of Alzheimer's disease.阿尔茨海默病的遗传学。
Clin Interv Aging. 2014 Apr 1;9:535-51. doi: 10.2147/CIA.S51571. eCollection 2014.
8
Mutational analysis in early-onset familial Alzheimer's disease in Mainland China.中国大陆早发性家族性阿尔茨海默病的突变分析
Neurobiol Aging. 2014 Aug;35(8):1957.e1-6. doi: 10.1016/j.neurobiolaging.2014.02.014. Epub 2014 Feb 20.
9
Predicting the functional effect of amino acid substitutions and indels.预测氨基酸替换和缺失的功能效应。
PLoS One. 2012;7(10):e46688. doi: 10.1371/journal.pone.0046688. Epub 2012 Oct 8.
10
Template-based protein structure modeling using the RaptorX web server.基于模板的蛋白质结构建模使用 RaptorX 网络服务器。
Nat Protoc. 2012 Jul 19;7(8):1511-22. doi: 10.1038/nprot.2012.085.